ULOQ [Study As­sess­ment]

posted by Anand – India, 2017-10-30 06:38 (1020 d 08:19 ago) – Posting: # 17945
Views: 7,390

Dear All,

Request to clarify,

In our Pivotal BE Study ULOQ was observed, whether we should exclude from PK?
After Dilution also it found ULOQ.
Method should be redeveloped or revalidated?
If included,What justification we should provide to Regulatory Agency?

Thanks in advance.

Regards,
A.A


Edit: Category changed; see also this post #1. [Helmut]

Complete thread:

Activity
 Admin contact
21,027 posts in 4,382 threads, 1,460 registered users;
online 18 (0 registered, 18 guests [including 11 identified bots]).
Forum time: Saturday 15:57 CEST (Europe/Vienna)

It has yet to be proven
that intelligence has any survival value.    Arthur C. Clarke

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5